Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Guozhong Venture Capital
BioCentury | Nov 3, 2022
Deals
Nov. 2 Quick Takes: CSL paying $200M for Arcturus’ mRNA vaccine tech
Plus Rubius seeking alternatives and updates from Horizon, Lilly-Innovent, GSK, Compass, Regeneron, Exelixis, CFIUS and more
BioCentury | Oct 12, 2021
Product Development
Oct. 11 Quick Takes: Supernus diversifies CNS portfolio with Adamas acquisition
Plus: Idorsia’s miss, Evotec, Protagonist, Enzyvant and Chance
BioCentury | Jul 9, 2020
Finance
July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn
BioCentury | Mar 25, 2020
Finance
March 24 Quick Takes: Apexigen brings series C to $123M; plus Nanjing F&S, FCA and Asieris
BioCentury | Aug 10, 2019
Financial News
Aug. 9 Financial Quick Takes: Ironwood, Clovis, MeiraGTx, Dynavax, Biocytogen and more
Items per page:
1 - 5 of 5